These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6991318)

  • 21. Effect of Calcitonin on plasma glucose, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetic subjects.
    Sgambato S; Passariello N; Giugliano D; Torella R; D'Onofrio F
    Acta Diabetol Lat; 1981; 18(3):235-41. PubMed ID: 7029989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of exogenous growth hormone on insulin requirements during closed loop insulin delivery in insulin-dependent diabetes mellitus.
    Bright GM; Melton RW; Rogol AD; Clarke WL
    Horm Metab Res; 1984 Jun; 16(6):286-9. PubMed ID: 6389295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overnight basal insulin requirements in insulin dependent diabetics.
    Vague P; Moulin JP; Souid J; Lassmann V; Vialettes B
    Diabete Metab; 1983 Dec; 9(4):288-91. PubMed ID: 6365641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of hyperglucagonaemia on blood glucose concentrations and on insulin requirements during fasting in insulin dependent diabetes mellitus.
    Clarke WL; Melton TW; Bright GM
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):557-60. PubMed ID: 6342325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some aspects of circadian variations of carbohydrate metabolism and related hormones in man.
    Sensi S
    Chronobiologia; 1974; 1(4):396-404. PubMed ID: 4619798
    [No Abstract]   [Full Text] [Related]  

  • 26. Hormonal responses to insulin infusion in diabetes mellitus.
    Campbell LV; Kraegen EW; Meler H; Lazarus L
    Diabetologia; 1979 Jun; 16(6):359-64. PubMed ID: 467845
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of "diabetogenic" hormones on carbohydrate and lipid metabolism following oral glucose loading in insulin dependent diabetics: effects of acute hormone administration.
    Bratusch-Marrain P; Waldhäusl W; Grubeck-Loebenstein B; Korn A; Vierhapper H; Nowotny P
    Diabetologia; 1981 Oct; 21(4):387-93. PubMed ID: 7286498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diurnal variations in plasma prolactin, growth hormone, cortisol and blood glucose in labile diabetes mellitus.
    Drejer J; Hendriksen C; Nielsen LM; Binder C; Hagen C; Kehlet H
    Clin Endocrinol (Oxf); 1977 Jan; 6(1):57-64. PubMed ID: 557382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dawn phenomenon: comparison between normal and insulin-dependent diabetic adolescents.
    Arslanian S; Ohki Y; Becker DJ; Drash AL
    Pediatr Res; 1992 Mar; 31(3):203-6. PubMed ID: 1313957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose.
    Goodner CJ; Conway MJ; Werbach JH
    J Clin Invest; 1969 Oct; 48(10):1878-87. PubMed ID: 5822593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
    Neuhaus C; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early-morning hyperglycemia in IDDM. Acute effects of cholinergic blockade.
    Atiea JA; Creagh F; Page M; Owens DR; Scanlon MF; Peters JR
    Diabetes Care; 1989; 12(7):443-8. PubMed ID: 2667925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose.
    Shapiro ET; Tillil H; Polonsky KS; Fang VS; Rubenstein AH; Van Cauter E
    J Clin Endocrinol Metab; 1988 Aug; 67(2):307-14. PubMed ID: 3292558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon response to hypoglycemia in diabetic neuropathy.
    Maher TD
    Horm Metab Res Suppl; 1980; 9():87-9. PubMed ID: 6929783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inappropriate counter-regulatory hormone levels in insulin treated diabetes.
    Danowski TS; Fisher ER; Kozak W; Bahl VK; Stephan T; Nolan S; Ahmad U
    Behav Neuropsychiatry; 1976 Apr-1977 Mar; 8(1-12):6-15. PubMed ID: 1052263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal responses during treatment of acute diabetic ketoacidosis with constant insulin infusions.
    Scott RS; Espiner EA; Donald RA; Livesey JH
    Clin Endocrinol (Oxf); 1978 Nov; 9(5):463-74. PubMed ID: 102471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM.
    Taskinen MR; Sane T; Helve E; Karonen SL; Nikkilä EA; Yki-Järvinen H
    Diabetes; 1989 May; 38(5):580-8. PubMed ID: 2653929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of a glucose controlled insulin infusion system (artificial beta cell) to control diabetes during surgery.
    Schwartz SS; Horwitz DL; Zehfus B; Langer B; Moossa AR; Ribeiro G; Kaplan E; Rubenstein AH
    Diabetologia; 1979 Mar; 16(3):157-64. PubMed ID: 428685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.